Clinical Trials

Phase EARLY_PHASE1 Recruiting

75 enrolled

Immunoglobulin G4-Related Disease, Arthritis, Rheumatoid, Lupus Nephritis, Multiple Sclerosis, Myasthenia Gravis

NCT07337785 2026-05-12

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

36 enrolled

Multiple Sclerosis, Myasthenia Gravis, Recurrence, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT07526493 2026-05-12

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

6 enrolled

Multiple Sclerosis, Myasthenia Gravis, Myositis, Neuromyelitis Optica, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT07085676 2026-05-06

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

120 enrolled

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Multiple Sclerosis, Myasthenia Gravis, Myositis, Neuromyelitis Optica, Scleroderma, Systemic, Antiphospholipid Syndrome, Multiple Sclerosis, Chronic Progressive

NCT07532707 2026-04-16

Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.

50 enrolled

Myasthenia Gravis

NCT06754020 2026-04-13

TCM Tongue Diagnosis and Syndrome Differentiation in Myasthenia Gravis Compared to Healthy Controls

100 enrolled

Myasthenia Gravis

NCT07499323 2026-04-08

Talquetamab in Patients With Refractory Generalized Myasthenia Gravis

2 enrolled

Myasthenia Gravis

NCT06491238 2026-03-23

MG-Ex

20 enrolled

Myasthenia Gravis

NCT07413835 2026-03-18

Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)

6 enrolled

Myasthenia Gravis

NCT07478172 2026-03-17

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

50 enrolled

Amyotrophic Lateral Sclerosis, Charcot-Marie-Tooth Disease, Glycogen Storage Disease Type II, Muscular Atrophy, Spinal, Myasthenia Gravis, Neuromuscular Diseases, Spastic Paraplegia, Hereditary, Lambert-Eaton Myasthenic Syndrome, Postpoliomyelitis Syndrome, Motor Neuron Disease, Mitochondrial Myopathies, Myopathies, Nemaline, Myositis, Inclusion Body, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Muscular Dystrophy, Facioscapulohumeral, Myopathies, Structural, Congenital, Postural Orthostatic Tachycardia Syndrome

NCT07470151 2026-03-13

Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

12 enrolled

Autoimmune Diseases, Lupus Erythematosus, Systemic, Myasthenia Gravis, Scleroderma, Diffuse

NCT07298928 2026-03-06

A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis

Phase 2 Active not recruiting

Myasthenia Gravis

NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

53 enrolled

CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

NCT07215949 2026-02-23

Zilucoplan for Severe gMG Exacerbations

Phase 3 Recruiting

15 enrolled

Myasthenia Gravis

NCT07392528 2026-02-11

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

Phase EARLY_PHASE1 Not yet recruiting

15 enrolled

Multiple Sclerosis, Myasthenia Gravis, Neuromyelitis Optica

NCT07372807 2026-01-28

RIPERT-MG

Phase 1/2 Not yet recruiting

20 enrolled

Myasthenia Gravis

NCT07323316 2026-01-07

HARMONY 360

100 enrolled

Myasthenia Gravis

NCT07291713 2025-12-18

Psychological Health and Adverse Childhood Experiences in Myasthenia Gravis: Online Mental Health BMI Learning Program

Phase EARLY_PHASE1 Recruiting

77 enrolled

Emotional Regulation, Psychological Well-Being, Depression, Myasthenia Gravis, Stress, Psychological

NCT06939166 2025-12-15

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases

12 enrolled

Multiple Sclerosis, Myasthenia Gravis, Neuromyelitis Optica, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT07072988 2025-09-24

OPTIMAGE

Phase 4 Recruiting

50 enrolled

Myasthenia Gravis

NCT05230082 2025-09-18

Acupuncture in Myasthenia Gravis (AcuMG)

Phase EARLY_PHASE1 Completed

24 enrolled 12 charts

Myasthenia Gravis

NCT04431895 2025-09-16

Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study

19 enrolled

Myasthenia Gravis

NCT06371040 2025-09-15

Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis

9 enrolled

Myasthenia Gravis

NCT06659627 2025-09-09

FIT to ACT-MG

Phase EARLY_PHASE1 Recruiting

60 enrolled

Fatigue, Myasthenia Gravis

NCT07058298 2025-09-08

GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)

6 enrolled

Myasthenia Gravis

NCT07154095 2025-09-04

A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants

Phase 1 Completed

40 enrolled

Myasthenia Gravis

NCT07136844 2025-08-22

Acti-Adult

300 enrolled

Other

Charcot-Marie-Tooth Disease, Huntington Disease, Myasthenia Gravis, Myotonic Dystrophy, Neuromuscular Diseases, Obesity, Supranuclear Palsy, Progressive, Spastic Paraplegia, Hereditary, Lambert-Eaton Myasthenic Syndrome, Muscular Dystrophy, Facioscapulohumeral, Spinocerebellar Ataxias

NCT07125105 2025-08-15

APART-MG

102 enrolled

Myasthenia Gravis

NCT05979688 2025-08-08

Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis

13 enrolled

Amyotrophic Lateral Sclerosis, Myasthenia Gravis

NCT05868837 2025-08-01

REFINE

Phase 3 Recruiting

40 enrolled

Myasthenia Gravis

NCT06765161 2025-07-29

Efgartigimod in IVIG Dependent Myasthenia Gravis Patients

Phase 3 Recruiting

Myasthenia Gravis

NCT06249438 2025-07-25

CAR-AID

Phase NA Active not recruiting

Lupus Erythematosus, Systemic, Multiple Sclerosis, Myasthenia Gravis, Neuromyelitis Optica, Scleroderma, Systemic

NCT07071246 2025-07-17

Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis

Myasthenia Gravis

NCT06158815 2025-07-15

Investigation of the Effects of Proprioceptive Neuromuscular Facilitation Exercises in Patients With Myasthenia Gravis

Phase EARLY_PHASE1 Withdrawn

23 enrolled

Myasthenia Gravis

NCT04965987 2025-07-11

Oxaloacetate in Myasthenia Gravis

Phase 1 Withdrawn

Myasthenia Gravis

NCT06419166 2025-06-27

gMG

Myasthenia Gravis

NCT07022197 2025-06-15

Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases

Phase 1/2 Recruiting

27 enrolled

Myasthenia Gravis, Myositis, Neuromyelitis Optica, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT03818204 2025-06-13

Clinical Trial to Improve the Magnetic Levator Prosthesis

19 enrolled 5 charts

Brain Injuries, Traumatic, Blepharoptosis, Myasthenia Gravis, Stroke

NCT06869278 2025-06-11

A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases

37 enrolled

Multiple Sclerosis, Myasthenia Gravis, Recurrence

NCT06879210 2025-06-04

Application of Artificial Intelligence in Precision Medicine and Healthcare

Phase 1 Not yet recruiting

10 enrolled

Myasthenia Gravis

NCT06978738 2025-05-18

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

18 enrolled

Classical hematology

Immunoglobulin G4-Related Disease, Anemia, Hemolytic, Autoimmune, Lupus Erythematosus, Systemic, Myasthenia Gravis, Myositis, Scleroderma, Systemic, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

NCT05067348 2025-05-01

tMG

Phase 2 Recruiting

64 enrolled

Myasthenia Gravis

NCT04728425 2025-04-27

MG_SCIG

Phase 2 Completed

Myasthenia Gravis

NCT04678115 2025-04-22

Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis

Phase EARLY_PHASE1 Not yet recruiting

16 enrolled 8 charts

Brain Injuries, Traumatic, Blepharoptosis, Myasthenia Gravis, Ophthalmoplegia, Chronic Progressive External, Stroke

NCT06933563 2025-04-18

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis

18 enrolled

Myasthenia Gravis

NCT05564936 2025-04-11

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

144 enrolled

Myasthenia Gravis

NCT06064695 2025-04-10

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis

16 enrolled

Fatigue, Motor Activity, Myasthenia Gravis

NCT06436768 2025-04-02

Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis

62 enrolled

Myasthenia Gravis, Delayed Emergence from Anesthesia

NCT05992025 2025-03-30

DIG-MG